Journal of Pharmaceutical Analysis · 2020 · 15 citations · 12 references
MedicineCancer BiologyOncologyEpigeneticsMolecular OncologyRadiobiologyCancer EpigeneticsEpigenetic Alterations In CancerEpigenetic Regulation In CancerMalignant NeoplasmsRadiation CarcinogenesisRadiation TherapyAberrant Dna MethylationCellular RadiosensitivityDna Methylation ModulationEpigenetic Responses To RadiationRadiation Resistance MechanismsRadiotherapy ResistanceTenascin-c ExpressionTumor Radiosensitivity
Shengmai Yin (SMY) is a Chinese herbal decoction that effectively alleviates the side effects of radiotherapy in various cancers and helps achieve radiotherapy's clinical efficacy. In this study, we explored the interaction mechanism among SMY, DNA methylation, and nasopharyngeal carcinoma (NPC). We identified differences in DNA methylation levels in NPC CNE-2 cells and its radioresistant cells (CNE-2R) using the methylated DNA immunoprecipitation array and found that CNE-2R cells showed genome-wide changes in methylation status towards a state of hypomethylation. SMY may restore its original DNA methylation status, and thus, enhance radiosensitivity. Furthermore, we confirmed that the differential gene Tenascin-C (TNC) was overexpressed in CNE-2R cells and that SMY downregulated TNC expression. This downregulation of TNC inhibited NPC cell radiation resistance, migration, and invasion. Furthermore, we found that TNC was hypomethylated in CNE-2R cells and partially restored to a hypermethylated state after SMY intervention. DNA methyltransferases 3a may be the key protein in DNA methylation of TNC.
12
Structural basis for DNMT3A-mediated de novo DNA methylation
Zhimin Zhang, Rui Lu, Pengcheng Wang et al. · Nature · 2018 · 391 citations · Full text
Future of Radiotherapy in Nasopharyngeal Carcinoma
Xue-Song Sun, Xiao-Yun Li, Qiu-Yan Chen et al. · British Journal of Radiology · 2019 · 138 citations · Full text